Close

Now Playing: FDA to consider lifting safety warnings on Avandia, but is it too little, too late?

The FDA is expected to take another look at controversial diabetes drug Avandia after researchers at Duke have concluded the drug doesn't increase the risk of cardiovascular death as previously reported.